{"id":1693,"date":"2020-11-10T13:27:58","date_gmt":"2020-11-10T13:27:58","guid":{"rendered":"https:\/\/tris.sambrownprojects.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/"},"modified":"2024-06-03T11:10:13","modified_gmt":"2024-06-03T10:10:13","slug":"tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers","status":"publish","type":"post","link":"https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/","title":{"rendered":"Tris Pharma Launches New ADHD Portfolio Website for Patients and Caregivers"},"content":{"rendered":"\r\n<p><\/p>\r\n\r\n\r\n\r\n<p>MONMOUTH JUNCTION, NJ, November 10, 2020 \/ PRNewswire\/ &#8211; Tris Pharma, Inc. (&#8220;Tris&#8221;), a specialty pharmaceutical company with a robust portfolio of approved products and a late-stage pipeline of innovative product candidates for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related disorders, today announced the launch of a new website for patients and their caregivers.<\/p>\r\n\r\n\r\n\r\n<p>ADHD impacts people of all ages and is one of the most common neurobehavioral disorders in children. Given the large impact of the disorder, there\u2019s a need for ongoing education and access to resources that may help inform patients and caregivers about symptom management. Tris\u2019 new website addresses this need within the ADHD community. With the launch of this new resource, patients and caregivers can learn more about ADHD and the multiple treatment options that are available from Tris. The website\u2019s streamlined design and simple navigation make it easy for members of the ADHD community to find the information they are looking for. &nbsp;&nbsp;&nbsp;<\/p>\r\n\r\n\r\n\r\n<p>&nbsp;<strong>Tris\u2019 ADHD Portfolio Website for Patients and Caregivers: &nbsp;<\/strong><a href=\"https:\/\/www.trisadhd.com\/\">https:\/\/www.trisadhd.com\/<\/a><\/p>\r\n\r\n\r\n\r\n<p>\u201cThe launch of our new consumer website is another example of Tris\u2019 continued commitment to educating people about ADHD\u201d, said Michelle Perlman, Senior Director of Marketing. \u201cThe website offers a better user experience, which I think consumers will appreciate. I\u2019m proud to be part of an organization that continues to invest in the research and development of educational resources and valuable treatment options that serve the ADHD community.\u201d<\/p>\r\n\r\n\r\n\r\n<p><strong>About Tris Pharma<\/strong> Tris Pharma is a New Jersey-based specialty pharmaceutical company focused on the development and commercialization of innovative medicines that address unmet patient needs. &nbsp;Tris has used its innovative LiquiXR technology platform to develop its portfolio of differentiated solid and liquid ADHD products (described at <a href=\"http:\/\/www.TrisADHD.com\">www.TrisADHD.com<\/a>), which it markets in the United States using its pediatric and CNS-focused sales force.&nbsp; The company has leveraged its technology platform to establish a robust product pipeline as well as numerous mutually value-adding development partnerships.&nbsp; For more information, please visit www.trispharma.com.<\/p>\r\n\r\n\r\n\r\n<p><\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>MONMOUTH JUNCTION, NJ, November 10, 2020 \/ PRNewswire\/ &#8211; Tris Pharma, Inc. (&#8220;Tris&#8221;), a specialty pharmaceutical company with a robust portfolio of approved products and a late-stage pipeline of innovative product candidates for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related disorders, today announced the launch of a new website for patients and [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_wp_rev_ctl_limit":""},"categories":[28],"tags":[],"class_list":["post-1693","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"featured_image_src":{"landsacpe":false,"list":false,"medium":false,"full":false},"yoast_head":"\n<title>Tris Pharma Launches New ADHD Portfolio Website for Patients and Caregivers - Tris Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tris Pharma Launches New ADHD Portfolio Website for Patients and Caregivers - Tris Pharma\" \/>\n<meta property=\"og:description\" content=\"MONMOUTH JUNCTION, NJ, November 10, 2020 \/ PRNewswire\/ &#8211; Tris Pharma, Inc. (&#8220;Tris&#8221;), a specialty pharmaceutical company with a robust portfolio of approved products and a late-stage pipeline of innovative product candidates for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related disorders, today announced the launch of a new website for patients and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/\" \/>\n<meta property=\"og:site_name\" content=\"Tris Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-10T13:27:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-03T10:10:13+00:00\" \/>\n<meta name=\"author\" content=\"rajeshlohakare@sambrown.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"rajeshlohakare@sambrown.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/\",\"url\":\"https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/\",\"name\":\"Tris Pharma Launches New ADHD Portfolio Website for Patients and Caregivers - Tris Pharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.trispharma.com\/#website\"},\"datePublished\":\"2020-11-10T13:27:58+00:00\",\"dateModified\":\"2024-06-03T10:10:13+00:00\",\"author\":{\"@id\":\"https:\/\/www.trispharma.com\/#\/schema\/person\/a23b5071b857390e7221beef1ae32be2\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.trispharma.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tris Pharma Launches New ADHD Portfolio Website for Patients and Caregivers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.trispharma.com\/#website\",\"url\":\"https:\/\/www.trispharma.com\/\",\"name\":\"Tris Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.trispharma.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.trispharma.com\/#\/schema\/person\/a23b5071b857390e7221beef1ae32be2\",\"name\":\"rajeshlohakare@sambrown.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.trispharma.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/83cec6f9d7f6fd867342a65ffe372ccb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/83cec6f9d7f6fd867342a65ffe372ccb?s=96&d=mm&r=g\",\"caption\":\"rajeshlohakare@sambrown.com\"},\"sameAs\":[\"http:\/\/tris.sambrownprojects.com\"],\"url\":\"https:\/\/www.trispharma.com\/author\/rajeshlohakaresambrown-com\/\"}]}<\/script>\n","yoast_head_json":{"title":"Tris Pharma Launches New ADHD Portfolio Website for Patients and Caregivers - Tris Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/","og_locale":"en_GB","og_type":"article","og_title":"Tris Pharma Launches New ADHD Portfolio Website for Patients and Caregivers - Tris Pharma","og_description":"MONMOUTH JUNCTION, NJ, November 10, 2020 \/ PRNewswire\/ &#8211; Tris Pharma, Inc. (&#8220;Tris&#8221;), a specialty pharmaceutical company with a robust portfolio of approved products and a late-stage pipeline of innovative product candidates for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related disorders, today announced the launch of a new website for patients and [&hellip;]","og_url":"https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/","og_site_name":"Tris Pharma","article_published_time":"2020-11-10T13:27:58+00:00","article_modified_time":"2024-06-03T10:10:13+00:00","author":"rajeshlohakare@sambrown.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"rajeshlohakare@sambrown.com","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/","url":"https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/","name":"Tris Pharma Launches New ADHD Portfolio Website for Patients and Caregivers - Tris Pharma","isPartOf":{"@id":"https:\/\/www.trispharma.com\/#website"},"datePublished":"2020-11-10T13:27:58+00:00","dateModified":"2024-06-03T10:10:13+00:00","author":{"@id":"https:\/\/www.trispharma.com\/#\/schema\/person\/a23b5071b857390e7221beef1ae32be2"},"breadcrumb":{"@id":"https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.trispharma.com\/tris-pharma-launches-new-adhd-portfolio-website-for-patients-and-caregivers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.trispharma.com\/"},{"@type":"ListItem","position":2,"name":"Tris Pharma Launches New ADHD Portfolio Website for Patients and Caregivers"}]},{"@type":"WebSite","@id":"https:\/\/www.trispharma.com\/#website","url":"https:\/\/www.trispharma.com\/","name":"Tris Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.trispharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.trispharma.com\/#\/schema\/person\/a23b5071b857390e7221beef1ae32be2","name":"rajeshlohakare@sambrown.com","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.trispharma.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/83cec6f9d7f6fd867342a65ffe372ccb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/83cec6f9d7f6fd867342a65ffe372ccb?s=96&d=mm&r=g","caption":"rajeshlohakare@sambrown.com"},"sameAs":["http:\/\/tris.sambrownprojects.com"],"url":"https:\/\/www.trispharma.com\/author\/rajeshlohakaresambrown-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/posts\/1693"}],"collection":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/comments?post=1693"}],"version-history":[{"count":1,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/posts\/1693\/revisions"}],"predecessor-version":[{"id":2928,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/posts\/1693\/revisions\/2928"}],"wp:attachment":[{"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/media?parent=1693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/categories?post=1693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.trispharma.com\/wp-json\/wp\/v2\/tags?post=1693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}